As of May 29, 2025, cbdMD Inc (YCBD) reports a Net Margin of -18.99%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of cbdMD Inc's Net Margin
Over recent years, cbdMD Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-09-30 | -18.99% |
| 2023-09-30 | -94.96% |
| 2022-09-30 | -197.97% |
| 2021-09-30 | -52.59% |
| 2020-09-30 | 30.09% |
This slight upward trend highlights how cbdMD Inc manages its overall profitability and cost control over time.
Comparing cbdMD Inc's Net Margin to Peers
To better understand cbdMD Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| cbdMD Inc (YCBD) | -18.99% |
| AcelRx Pharmaceuticals Inc (ACRX) | 2698.31% |
| Medexus Pharmaceuticals Inc (MDP.V) | 1.13% |
| High Tide Inc (HITI.V) | -0.83% |
| Harrow Health Inc (HROW) | -8.76% |
| Qilian International Holding Group Ltd (QLI) | -16.74% |
Compared to its competitors, cbdMD Inc's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.